MedTrace Logo

Baclofen as a Perioperative Analgesic Adjuvant

NCT03720717 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-09-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether a single, oral dose of baclofen alters postoperative opioid requirements.

Conditions

Interventions

DRUG

Baclofen 10mg

Baclofen administration pre-operatively

OTHER

Placebo

Placebo administration

Sponsors & Collaborators

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Mark Mandabach, MD · University of Alabama at Birmingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-27
Primary Completion
2022-10-28
Completion
2022-10-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03720717 on ClinicalTrials.gov